Status:
COMPLETED
A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy
Lead Sponsor:
UCB Pharma
Conditions:
Diabetic Neuropathy
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This trial was conducted at about 50 sites in Europe and has been clinically completed. Patients had symptoms of painful diabetic neuropathy for 6 months up to 5 years with an optimized diabetic contr...
Eligibility Criteria
Inclusion
- Painful distal diabetic neuropathy
Exclusion
- Symptoms of painful distal diabetic neuropathy for less than six months or greater than 5 years
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
357 Patients enrolled
Trial Details
Trial ID
NCT00238524
Start Date
December 1 2003
End Date
January 1 2005
Last Update
September 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schwarz
Monheim, Germany